LLY Jun 2023 310.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
At close: 10:43AM EST
| Previous Close | 45.95 |
| Open | 49.70 |
| Bid | 44.20 |
| Ask | 47.30 |
| Strike | 310.00 |
| Expire Date | 2023-06-16 |
| Day's Range | 48.10 - 49.70 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 210 |
- Reuters
UPDATE 1-FDA approves Eli Lilly's blood cancer drug
Eli Lilly and Co said on Friday the U.S. health regulator approved its drug for the treatment of a rare form of blood cancer. The Food and Drug Administration gave accelerated approval to Jaypirca for the treatment of adults mantle cell lymphoma after at least two lines of therapy.
- Zacks
FDA Pulls EUA Granted to AstraZeneca's (AZN) Evusheld
AstraZeneca's (AZN) Evusheld is no longer authorized for use in the United States after laboratory data showed that it does not neutralize Omicron subvariants.
- Zacks
Biogen (BIIB) & Eisai's Lecanemab Secures EMA's MAA Acceptance
Biogen (BIIB) and Eisai jointly announce that EMA accepts lecanemab's marketing authorization application (MAA) for the treatment of patients with early-stage Alzheimer's disease, for review.
© 2023 Yahoo. All rights reserved.
